JB Pharma manufactures and markets pharmaceutical formulations, herbal products, and APIs, while also providing product development services. Its products include oral solids, injectables, liquids, and lozenges across multiple therapeutic areas.

The Company operates in India and exports to over 40 international markets, supported by four international subsidiaries. Generics are exported to the USA, UK, South Africa, Australia, and Canada, while branded generics reach Africa, South-East Asia, the Gulf, the Middle East, Central, and South America.

Exports contribute 38% of total turnover, with the balance from domestic operations. Product-wise, oral solids contribute 56% of turnover, followed by injectables at 22%, liquids at 9%, and lozenges at 5%, together accounting for 90% of total revenue.